Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

Published:2016-03-03 Issue:2 Volume:3 Page:e211
ISSN:2332-7812
Container-title:Neurology - Neuroimmunology Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Lundy Steven K.,Wu Qi,Wang Qin,Dowling Catherine A.,Taitano Sophina H.,Mao Guangmei,Mao-Draayer Yang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Neurology

Reference39 articles.

1. Oral Disease-Modifying Therapies for Multiple Sclerosis

2. Established and novel disease-modifying treatments in multiple sclerosis

3. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

4. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

5. Dimethyl fumarate for treating relapsing multiple sclerosis

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate;Advances in Therapy;2024-06-11

2. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories;Science Translational Medicine;2024-03-27

3. Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis;Journal of Neuroimmunology;2023-09

4. Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients;Frontiers in Immunology;2023-07-07

5. UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus;Journal of Autoimmunity;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3